Journal of Biological Chemistry · 2002 · 314 citations · 26 references
Life SciencesBiochemistryEndocrinologyCell SignalingSignal TransductionSteroid BiochemistryHormone ReceptorsHormone SignalingReceptor BindingReceptor PharmacologyReceptor RegulationSteroid Hormone SignalingG Protein-coupled Hormone ReceptorsGlucocorticoid Mechanism Of ActionGlucocorticoid Receptor SignalingGlucocorticoid ReceptorsGlucocorticoid SignalingPhospho-protein AnalysisSteroid PhosphorylationTranscriptional Kinetics
The glucocorticoid receptor (GR) is phosphorylated at multiple serine residues in a hormone-dependent manner, yet progress on elucidating the function of GR phosphorylation has been hindered by the lack of a simple assay to detect receptor phosphorylation in vivo. We have produced antibodies that specifically recognize phosphorylation sites within human GR at Ser203 and Ser211. In the absence of hormone, the level of GR phosphorylation at Ser211 was low compared with phosphorylation at Ser203. Phosphorylation of both residues increased upon treatment with the GR agonist dexamethasone. Using a battery of agonists and antagonists, we found that the transcriptional activity of GR correlated with the amount of phosphorylation at Ser211, suggesting that Ser211 phosphorylation is a biomarker for activated GR in vivo. Mechanistically, the kinetics of Ser203 and Ser211 phosphorylation in response to hormone differed, with Ser211 displaying a more robust and sustained phosphorylation relative to Ser203. Analysis of GR immunoprecipitates with phospho-GR-specific antibodies indicated that the receptor was phosphorylated heterogeneously at Ser203 in the absence of hormone, whereas in the presence of hormone, a subpopulation of receptors was phosphorylated at both Ser203 and Ser211. Interestingly, biochemical fractionation studies following hormone treatment indicated that the Ser203-phosphorylated form of the receptor was predominantly cytoplasmic, whereas Ser211-phosphorylated GR was found in the nucleus. Likewise, by immunofluorescence, Ser203-phosphorylated GR was located in the cytoplasm and perinuclear regions of the cell, but not in the nucleoplasm, whereas strong phospho-Ser211 staining was evident in the nucleoplasm of hormone-treated cells. Our results suggest that differentially phosphorylated receptor species are located in unique subcellular compartments, likely modulating distinct aspects of receptor function. The glucocorticoid receptor (GR) is phosphorylated at multiple serine residues in a hormone-dependent manner, yet progress on elucidating the function of GR phosphorylation has been hindered by the lack of a simple assay to detect receptor phosphorylation in vivo. We have produced antibodies that specifically recognize phosphorylation sites within human GR at Ser203 and Ser211. In the absence of hormone, the level of GR phosphorylation at Ser211 was low compared with phosphorylation at Ser203. Phosphorylation of both residues increased upon treatment with the GR agonist dexamethasone. Using a battery of agonists and antagonists, we found that the transcriptional activity of GR correlated with the amount of phosphorylation at Ser211, suggesting that Ser211 phosphorylation is a biomarker for activated GR in vivo. Mechanistically, the kinetics of Ser203 and Ser211 phosphorylation in response to hormone differed, with Ser211 displaying a more robust and sustained phosphorylation relative to Ser203. Analysis of GR immunoprecipitates with phospho-GR-specific antibodies indicated that the receptor was phosphorylated heterogeneously at Ser203 in the absence of hormone, whereas in the presence of hormone, a subpopulation of receptors was phosphorylated at both Ser203 and Ser211. Interestingly, biochemical fractionation studies following hormone treatment indicated that the Ser203-phosphorylated form of the receptor was predominantly cytoplasmic, whereas Ser211-phosphorylated GR was found in the nucleus. Likewise, by immunofluorescence, Ser203-phosphorylated GR was located in the cytoplasm and perinuclear regions of the cell, but not in the nucleoplasm, whereas strong phospho-Ser211 staining was evident in the nucleoplasm of hormone-treated cells. Our results suggest that differentially phosphorylated receptor species are located in unique subcellular compartments, likely modulating distinct aspects of receptor function. glucocorticoid receptor (prefixes “m” and “h” represent mouse and human, respectively) hemagglutinin dexamethasone phosphate-buffered saline Tris-buffered saline The glucocorticoid receptor (GR)1 is a phosphoprotein that regulates a wide range of metabolic and developmental processes by controlling the expression of target genes in a hormone-dependent and cell-specific manner (1Reichardt H.M. Tuckermann J.P. Bauer A. Schutz G. Z. Rheumatol. 2000; 59: 1-5Crossref Scopus (42) Google Scholar, 2Yamamoto K.R. Annu. Rev. Genet. 1985; 19: 209-252Crossref PubMed Scopus (1328) Google Scholar). GR is structurally similar to other members of the nuclear receptor superfamily in that separate receptor activities such as DNA and ligand binding are localized to distinct regions of the protein (3Weinberger C. Hollenberg S.M. Rosenfeld M.G. Evans R.M. Nature. 1985; 318: 670-672Crossref PubMed Scopus (219) Google Scholar, 4Hollenberg S.M. Weinberger C. Ong E.S. Cerelli G. Oro A. Lebo R. Thompson E.B. Rosenfeld M.G. Evans R.M. Nature. 1985; 318: 635-641Crossref PubMed Scopus (1430) Google Scholar). GR contains a constitutive activation function (AF-1) in the N terminus and a ligand-dependent function (AF-2) in the C terminus (5Godowski P.J. Rusconi S. Miesfeld R. Yamamoto K.R. Nature. 1987; 325: 365-368Crossref PubMed Scopus (282) Google Scholar). In the absence of ligand, the hsp90-based chaperone complex represses GR regulatory activities (6Pratt W.B. Toft D.O. Endocr. Rev. 1997; 18: 306-360Crossref PubMed Scopus (1514) Google Scholar). Hormone binding relieves this repression and results in a conformational change in the receptor, which, in turn, promotes GR-DNA binding, association with additional transcriptional regulatory cofactors, and regulation of target genes (7Jenkins B.D. Pullen C.B. Darimont B.D. Trends Endocrinol. Metab. 2001; 12: 122-126Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar). Although ligand binding is essential for the activation of GR, the receptor is also subject to post-translational modification through phosphorylation (8Bodwell J.E. Webster J.C. Jewell C.M. Cidlowski J.A., Hu, J.M. Munck A. . Mol. Biol. 1998; 65: 91-99Google Scholar). GR is phosphorylated in the absence of hormone, with additional phosphorylation occurring in conjunction with agonist (but not antagonist) binding. Orti et al. (9Orti E., Hu, L.M. Munck A. J. Biol. Chem. 1993; 268: 7779-7784Abstract Full Text PDF PubMed Google Scholar) showed that GR is hyperphosphorylated after it becomes activated and acquires the ability to bind to DNA. It has been suggested that hormone-dependent phosphorylation of GR may determine target promoter specificity, cofactor interaction, strength and duration of receptor signaling, and receptor stability (10Garabedian M.J. Rogatsky I. Hittelman A.H. Knoblauch R. Trowbridge J.T. Krstic M.D. Freedman L.P. Molecular Biology of Steroid and Nuclear Hormone Receptors. Birkhaeuser Boston, Inc., Cambridge, MA1998: 237-260Crossref Google Scholar). Bodwell et al. (11Bodwell J.E. Orti E. Coull J.M. Pappin D.J. Smith L.I. Swift F. J. Biol. Chem. 1991; 266: 7549-7555Abstract Full Text PDF PubMed Google Scholar) have identified seven phosphorylation sites in mouse GR (mGR) overexpressed in Chinese hamster ovary cells by direct sequencing of phosphorylated peptides. All seven phosphorylated residues are clustered in the N-terminal region of the receptor. Through peptide mapping and mutagenesis studies, our laboratory has identified four predominant sites of phosphorylation in rat GR expressed in mammalian cells and in yeast that coincide with a subset of sites identified in mGR (12Pocuca N. Ruzdijic S. Demonacos C. Kanazir D. Krstic-Demonacos M. J. Steroid Biochem. Mol. Biol. 1998; 66: 303-318Crossref PubMed Scopus (11) Google Scholar, 13Krstic M.D. Rogatsky I. Yamamoto K.R. Garabedian M.J. Mol. Cell. Biol. 1997; 17: 3947-3954Crossref PubMed Scopus (228) Google Scholar). Among them, two sites, Ser224 and Ser232, corresponding to Ser203 and Ser211 in human GR (hGR), are phosphorylated to a greater extent in the presence of hormone. We have also identified the cyclin-dependent kinases as potential kinases that modify Ser224 and Ser232 in vitro. Mutations in the cyclin-dependent kinase catalytic subunit p34 CDC28 or regulatory cyclin subunits reduce receptor-dependent transcriptional activation in a reconstituted GR signaling system in yeast, indicating that cyclin-dependent kinase function is necessary for full receptor-mediated transcriptional enhancement (13Krstic M.D. Rogatsky I. Yamamoto K.R. Garabedian M.J. Mol. Cell. Biol. 1997; 17: 3947-3954Crossref PubMed Scopus (228) Google Scholar). Previous studies by Mason and Housley (14Mason S.A. Housley P.R. J. Biol. Chem. 1993; 268: 21501-21504Abstract Full Text PDF PubMed Google Scholar) suggest that single or multiple phosphorylation site mutations in mGR have little effect on receptor transcriptional activation, subcellular localization, or activity in response to cAMP treatment. Similar results were obtained by Almlöf et al. (15Almlöf T. Wright A.P. Gustafsson J.-Å. J. Biol. Chem. 1995; 270: 17535-17540Abstract Full Text Full Text PDF PubMed Scopus (89) Google Scholar) when phosphorylation site mutants in hGR were analyzed in yeast. Webster et al. (16Webster J.C. Jewell C.M. Bodwell J.E. Munck A. Sar M. Cidlowski J.A. J. Biol. Chem. 1997; 272: 9287-9293Abstract Full Text Full Text PDF PubMed Scopus (216) Google Scholar) reported that single or multiple phosphorylation site mutations have little effect on mGR expression, nuclear translocation, and transcriptional activation from a complex murine mammary tumor virus promoter. Importantly, they also showed that the phosphorylation status of mGR has a substantial effect on transcriptional activation from a GR-responsive reporter containing a minimal E1b promoter, suggesting that the effect of GR phosphorylation on transcriptional activation is promoter-specific. However, the mechanism by which phosphorylation affects GR transcriptional regulation remains enigmatic. To gain further insight into the function of GR phosphorylationin vivo, we have developed antibodies that specifically recognize hGR phosphorylated at either Ser203 or Ser211. Using these novel reagents, we examined the kinetics of hormone-dependent GR phosphorylation and the extent of receptor phosphorylation in response to a battery of agonists and antagonists as well as the subcellular localization of phosphorylated GR in cultured cells and in human tissues. Our findings indicate that GR phosphorylation is a dynamic process, with differentially phosphorylated receptor species partitioned into distinct subcellular compartments, likely affecting distinct aspects of receptor function in vivo. Phosphopeptides corresponding to hGR sequences194LQDLEFSSGS(PO4)PGKE207 and202GSPGKETNES(PO4)PWRS215 were synthesized by Anaspec Inc. (San Jose, CA). A cysteine residue was added to the N terminus of each peptide to facilitate chemical cross-linking. Each phosphopeptide was coupled to keyhole limpet hemocyanin and used to immunize rabbits (Covance Research Products, Inc., Denver, PA). Sera from immunized rabbits were tested for antibody titer and specificity for the phosphorylated peptides by enzyme-linked immunosorbent assay. High titer antibodies were further tested on hGR or rat GR expressed in U2OS or Saos-2 cells by immunoblotting. The human lung carcinoma containing GR and the human U2OS GR were obtained from and were cultured in with either or and of U2OS hGR and phosphorylation site mutants and was as I. Trowbridge J.M. Garabedian M.J. Mol. Cell. Biol. 1997; 17: PubMed Scopus (219) Google Scholar). were at a of to were the with of or phosphorylation site or were by cells in the presence of for were and for hGR expression by and with and were in for were from a of and cells with or of to were on with saline and in of containing and additional and and Molecular were at for at The were for protein the protein and the were for in and at from human were from as by the or immunoprecipitates containing GR were by and to at for in The were in in saline at and in with antibody at for and of for phospho-Ser211 and and antibodies were also and results to with the were GR was the residues of The were for with and and with and for at with protein A to the antibody Molecular a antibody was were for with and and with and developed to the of was the the GR phosphorylation antibodies and phospho-Ser211 and antibody were to protein in at for and with to the were with of protein from at on a for or were with and with in and at cells were cultured in containing on with and were with or for were in for and in containing for to protein binding. were with antibodies in for at and with and by with or antibody Inc., in for at antibody was by the cells with and and with were Inc., and the was and a was used to phospho-Ser211 in human by Molecular of were for in and at through in and in were on a and on were in and with were in a for in with for with and with for were with antibody in and a antibody was and complex and was developed were with Nuclear were as A. PubMed Scopus Google Scholar). cells single were with into a and by at for at of A and a was and the cells were to on for were by through a with a at The of was by The was in a at for at The was and as the The nuclear was in of a of and and on with for The nuclear was by for at and the was as the nuclear Each was to protein with A or and of was for and at The antibodies in this and were and corresponding to residues and of Although GR is phosphorylated at multiple sites, we to antibodies and they within the minimal region as by a GR GR that GR by a activation J.A. Yamamoto K.R. J. Biol. Chem. 1997; 272: Full Text Full Text PDF PubMed Scopus Google Scholar). The antibodies were tested for ability to detect GR by of from U2OS cells of hGR either or for with The antibody GR from both and hormone-treated cells and showed greater GR from cells with The antibody showed substantial GR from but not from cells and of GR were as by for GR the on the receptor and GR was with not results indicate that Ser203 is phosphorylated in the absence and more in the presence of hormone, whereas Ser211 is phosphorylated predominantly in the presence of hormone. a for specificity, we tested the ability of the antibodies to detect of GR and in U2OS cells and The not recognize the GR in either the absence or presence of and but the GR to a similar extent as The for the it not detect the hGR and but was with the in a hormone-dependent manner and to a extent with GR The that the phosphorylation at Ser211 of these two sites on each such that Ser203 may to phosphorylated phosphorylation at Ser211 The amount of GR in each was as by with the antibody each antibody GR phosphorylation site We examined GR phosphorylation in the human lung carcinoma which in U2OS cells the level of hGR phosphorylation in cells at Ser211 was low compared with phosphorylation at Ser203 in the absence of hormone. Phosphorylation of both residues increased upon treatment with the agonist dexamethasone the and are of phosphorylation of GR from a cultured We also hGR phosphorylation in of human by the four GR-responsive examined and and phospho-Ser211 was in the and whereas was in the The for We were to detect in the lung upon not a amount of GR was and from human To determine which the Ser211-phosphorylated form of GR, of human were examined by with either the or antibody that GR of phosphorylation A of a human showed strong phospho-Ser211 within the of a in the staining for the of cells with the whereas both the cytoplasm and of cells of the In lung showed little within the of cytoplasm for the GR low level of is with the results from the of lung Although cells showed phospho-Ser211 in the lung to Ser211-phosphorylated GR, indicating that the staining the form of GR is in in a subset of human tissues. The of glucocorticoid agonists and antagonists on phosphorylation of GR was also of glucocorticoid agonists and and two of glucocorticoid antagonists and were tested for ability to GR phosphorylation and to transcriptional activation after of treatment. in and Ser211 whereas to Ser211, a in the GR transcriptional activation assay. and the amount of receptor phosphorylation effect on the phosphorylation of either Ser203 or Ser211. In a of the of Ser211 A of was not as at the phosphorylation of GR, of for the receptor. results suggest that the transcriptional activity with GR indicating association receptor-dependent transcriptional enhancement and Ser211 To the kinetics of phosphorylation of Ser203 and Ser211, we on at of treatment the and antibodies The antibody was used to determine the amount of The relative amount of for each was Hormone treatment little effect on GR at but in a in GR that at of hormone treatment and for such a in GR protein has been to increased GR and protein Jewell C.M. Sar M. Cidlowski J.A. Endocrinol. Google Scholar, J. Mol. Endocrinol. 2000; PubMed Scopus Google Scholar). GR was by by of hormone treatment. in phosphorylation at Ser211 increased within the of a within of hormone treatment. a Ser211 phosphorylation for after which the from to Phosphorylation at Ser203 increased at a similar to that at Ser211 within the of hormone treatment to GR protein at each Ser203 phosphorylation increased at of treatment and relative to GR and that Ser203 phosphorylation a at of treatment and the kinetics of of In Ser211 phosphorylation increased more and at a a at of hormone and at the as GR after hormone-dependent phosphorylation at Ser211 is more robust and sustained Ser203 The results from the indicated that GR is phosphorylated at Ser203 and Ser211 in the presence of However, this not receptors with a single at each site or receptor that are phosphorylated at Ser203 and To this GR was with or antibodies from of cells that been cultured with or for The immunoprecipitates were analyzed by with and the antibody amount of GR from and cells and The GR from cells and whereas the GR from hormone-treated and with more GR from the and The results are with the results from of and the that phosphorylation at Ser211 is whereas phosphorylation at Ser203 in the absence of hormone, but is increased upon hormone Importantly, the hGR Ser211 was by the antibody and indicating that GR phosphorylated at Ser203 and Ser211 a of GR that are phosphorylated at both Ser203 and Ser211 in vivo. The that phosphorylation at Ser203 is increased in response to hormone that not of GR is phosphorylated at Ser203. GR were phosphorylated at we that GR and immunoprecipitates the when with In GR were heterogeneously phosphorylated at we to from immunoprecipitates of GR which was and within a of GR in the absence of hormone in vivo, receptors are phosphorylated at whereas To determine the subcellular of GR we and nuclear from cells either or with for In the absence of hormone, GR was in the whereas after a the receptor was the and nuclear Interestingly, phosphorylation at Ser203 in the absence and presence of was in the of U2OS whereas phosphorylation at Ser211 was in both the and nuclear To the of the fractionation we examined each for the and nuclear a and a of the transcriptional regulatory was found predominantly in the whereas protein was in the nuclear the the and nuclear results suggest that Ser203 and Ser211 are phosphorylated in the cytoplasm and that the Ser211-phosphorylated form of the receptor in the after a hormone treatment. was with antibodies and results with the fractionation studies In the Ser203-phosphorylated form of the receptor was in the cytoplasm and perinuclear region of the cell, but not in the hormone the with perinuclear phospho-Ser211 was in the cytoplasm or of cells. In strong phospho-Ser211 staining was evident in the nucleoplasm of hormone-treated cells after a hormone with phospho-Ser211 in the staining is to was in and cells when examined with the and not these results suggest that the Ser203-phosphorylated form of GR is predominantly and whereas the Ser211-phosphorylated species is nuclear after hormone We also examined the subcellular of the hGR and phospho-Ser211 in cells was in strong phospho-Ser211 was in the of hormone-treated whereas the Ser203-phosphorylated form of the receptor was the perinuclear results our findings in cells and suggest that phosphorylated of GR to distinct subcellular We have antibodies that specifically recognize hGR phosphorylated at Ser203 and Ser211. antibodies with GR phosphorylation as by or suggesting that the antibodies detect the phosphorylated receptor in either or form and to a level of GR phosphorylation at but not at Ser211, and phosphorylation of both residues was increased upon treatment with is with the results metabolic studies (13Krstic M.D. Rogatsky I. Yamamoto K.R. Garabedian M.J. Mol. Cell. Biol. 1997; 17: 3947-3954Crossref PubMed Scopus (228) Google Scholar, Hu, Hu, J.M. Orti E. Munck A. J. Steroid Biochem. Mol. Biol. 1993; PubMed Scopus Google Scholar). The enhancement of phosphorylation at Ser203 was whereas for Ser211, it was after of treatment We also found a strong of GR and receptor agonists such as and robust GR phosphorylation at Ser211, whereas such as receptor phosphorylation The effect of on GR phosphorylation at Ser211 that the kinase this residue may to the receptor the with affecting this et al. D. T. E. J.M. S. Mol. Cell. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar) that the activity of is by phosphorylation as a of the ligand-dependent of a cyclin-dependent kinase through the GR phosphorylation at through a similar mechanism remains to phosphorylation at Ser211 may the receptor or with that facilitate with this GR with the cofactor was when Ser211 was to Hittelman and M. J. In the antibody was of GR within human as by phosphorylation at Ser211 may represent biomarker for the form of GR in vivo. The of Ser203 and in response to treatment showed that Ser211 phosphorylation was more sustained Ser203 suggesting that phosphorylation at Ser203 is more phosphorylation at Ser211. and phospho-Ser211 are differentially to the or represent for distinct or of Ser211 into the it from or promotes remains to It is to that of GR at the as Ser203 suggesting that modification of this residue a of ligand-dependent of with the of Webster et al. (16Webster J.C. Jewell C.M. Bodwell J.E. Munck A. Sar M. Cidlowski J.A. J. Biol. Chem. 1997; 272: 9287-9293Abstract Full Text Full Text PDF PubMed Scopus (216) Google Scholar) that phosphorylation site mutations that GR and that ligand-dependent localization of the indicated upon hormone the Ser203-phosphorylated form of the receptor was in the whereas Ser211-phosphorylated GR was evident in both the and nuclear Interestingly, by immunofluorescence, the Ser203-phosphorylated form of the receptor was to the cytoplasm and perinuclear regions of the cell, whereas the receptor phosphorylated at Ser211 localized to the nucleoplasm and cytoplasm after a hormone findings suggest that unique phosphorylated of the receptor are to distinct subcellular the GR phospho-Ser211 form to the nuclear subpopulation of the receptor, whereas the GR form is with receptor at the such as nuclear or GR phosphorylation may represent a or that that the receptor is for such as cofactor binding. of GR with phosphorylation may distinct aspects of receptor function in vivo. The phosphorylation antibodies a receptor, the receptor, were in of by et al. Mol. Endocrinol. 2000; PubMed Scopus Google Scholar). with GR, the receptor hormone-dependent phosphorylation sites are differentially However, GR, the receptor phosphorylated examined to in the nucleus. this in the phosphorylation sites examined GR and the receptor or in receptor kinases and that target these receptors further on our we a of GR by phosphorylation in the absence of hormone, the phosphorylated subpopulation of GR is at hormone treatment promotes phosphorylation of both Ser203 and Ser211, in the phosphorylated form of GR We that this phosphorylated of GR the receptor for in the of the receptor that in the nucleus. mechanism is to by kinases such as a phosphorylation the for modification R. E. S.M. N. Cell. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). GR and GR Ser203 the of GR phospho-Ser211 to GR The Ser211-phosphorylated form the phosphorylation remains from the to Ser211 in a receptor that a at either Ser203 or Ser211. The receptor two it either or receptors may into which facilitate Ser203 the form of that not with the chaperone complex are subject to is with studies in which treatment of cells with the GR by the J. Biol. Chem. 1997; 272: Full Text Full Text PDF PubMed Scopus Google Scholar). Although further necessary to phosphorylation promotes receptor or this of phosphorylation and likely a in modulating the response in vivo. and have been to with GR and to receptor function and phosphorylation M. Garabedian M.J. Mol. Endocrinol. 1991; PubMed Scopus Google Scholar, M.D. M. W.B. J. Biol. Chem. 1997; 272: Full Text Full Text PDF PubMed Scopus Google Scholar, Z. G. I. PubMed Scopus Google Scholar). of activity by results in GR a of the receptor from the to the and the of GR to the J.P. Mol. Endocrinol. Google Scholar). We that of the activity to of the phosphorylated form of GR in the cytoplasm by of into or increased from the nucleus. Our findings also on the kinases that target fractionation studies suggest that GR phosphorylation at both Ser203 and Ser211 in the with the Ser211-phosphorylated form in the nucleus. Previous results from our laboratory have that cyclin and cyclin GR at Ser203 and that cyclin Ser211 in (13Krstic M.D. Rogatsky I. Yamamoto K.R. Garabedian M.J. Mol. Cell. Biol. 1997; 17: 3947-3954Crossref PubMed Scopus (228) Google Scholar). the of these kinases are predominantly nuclear G. R. J. 1993; Google it is that they represent the receptor kinases that phosphorylation at Ser203 and Ser211 in the However, it is that two distinct and the other target Ser211 and that cyclin is the receptor kinase that promotes in the nucleus. In of the phosphorylation of by and cyclin-dependent kinases D. T. E. J.M. S. Mol. Cell. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, G. D. J. PubMed Scopus Google it is that GR may by multiple kinases upon the subcellular the receptor We suggest that modification of GR by phosphorylation distinct receptor association with additional that GR and Phosphorylation of GR a unique modification that is in the and cytoplasm to differentially receptor function. of phosphorylated receptor species with distinct may as a novel and mechanism hormone receptor We and Rogatsky for on the We are to and Yamamoto for antibody We also for staining and of the human We are to for on antibody with
26
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Stanley M. Hollenberg, Cary Weinberger, Estelita S. Ong et al. · Nature · 1985 · 1.9K citations · Full text
Crystal Structure of Glycogen Synthase Kinase 3β
Rana Dajani, Elizabeth Fraser, S. Mark Roe et al. · Cell · 2001 · 669 citations · Full text